Episode #77: The Impact of 340B Drug Pricing on Patient Care | Lisa Mathew & Brittany Panico | Summit Rheumatology Podcast Por arte de portada

Episode #77: The Impact of 340B Drug Pricing on Patient Care | Lisa Mathew & Brittany Panico | Summit Rheumatology

Episode #77: The Impact of 340B Drug Pricing on Patient Care | Lisa Mathew & Brittany Panico | Summit Rheumatology

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Dr. Lisa Mathew interviews Dr. Brittany Panico, a rheumatologist in Colorado Springs who recently wrote an op-ed calling for reforms to the 340B program to require more transparency and reporting on how 340B discounts are passed on to patients. The 340B Program is a federal drug pricing program that allows certain hospitals and clinics to buy medications at steep discounts to support medication access for underserved patients, with the expectation that these savings would be passed on to patients. But critics argue that the program's growth has led to unintended consequences, such as market consolidation. And some studies suggest that 340B discounts may not translate into increased care or lower costs for vulnerable populations. Join Dr. Mathew and Dr. Panico as they discuss Dr. Panico's experience as an employed physician in a 340B hospital system and as an independent physician, and how the lack of oversight in the program may be making it harder for specialists to deliver the best patient care. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 77, presented by TissueCypher from Castle Biosciences
adbl_web_global_use_to_activate_webcro805_stickypopup
Todavía no hay opiniones